Variant report
Variant | nsv527041 |
---|---|
Chromosome Location | chr16:82401055-82402782 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:7)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:7 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr16:82400970..82402265-chr16:82489997..82490801,4 | MCF-7 | breast: | |
2 | chr16:82401273..82402735-chr16:82489954..82490649,3 | MCF-7 | breast: | |
3 | chr16:82401433..82402195-chr16:82472965..82473907,2 | MCF-7 | breast: | |
4 | chr16:82362985..82363554-chr16:82401341..82402193,2 | MCF-7 | breast: | |
5 | chr16:82401188..82401863-chr16:82612795..82614499,6 | MCF-7 | breast: | |
6 | chr16:82401325..82403484-chr16:82424417..82426290,2 | K562 | blood: | |
7 | chr16:82401256..82401986-chr16:83102060..83102714,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs9937851 | chr16:82401055-82401056 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs374129344 | chr16:82401116-82401117 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs116845154 | chr16:82401123-82401124 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs576911063 | chr16:82401124-82401125 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs188113423 | chr16:82401134-82401135 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs552941373 | chr16:82401143-82401144 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs144928645 | chr16:82401170-82401171 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs541713364 | chr16:82401192-82401193 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs190245432 | chr16:82401198-82401199 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs182925424 | chr16:82401201-82401202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs149064802 | chr16:82401217-82401218 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs112742206 | chr16:82401218-82401219 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs143014181 | chr16:82401226-82401227 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs528188942 | chr16:82401231-82401232 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs546755923 | chr16:82401255-82401256 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs75841722 | chr16:82401259-82401260 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs368045888 | chr16:82401266-82401267 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs548571291 | chr16:82401276-82401277 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs187554740 | chr16:82401280-82401281 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs75806812 | chr16:82401293-82401294 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs192288505 | chr16:82401296-82401297 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs116709872 | chr16:82401299-82401300 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs146675423 | chr16:82401302-82401303 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs553053978 | chr16:82401339-82401340 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs140710465 | chr16:82401347-82401348 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs145918957 | chr16:82401376-82401377 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs112701162 | chr16:82401379-82401380 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs575475632 | chr16:82401404-82401405 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs545951370 | chr16:82401475-82401476 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs545823149 | chr16:82401478-82401479 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs561705288 | chr16:82401479-82401480 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs557971673 | chr16:82401507-82401508 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs185593476 | chr16:82401510-82401511 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs34667460 | chr16:82401513-82401514 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs4082513 | chr16:82401514-82401515 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs9940174 | chr16:82401515-82401516 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs561786874 | chr16:82401521-82401522 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs55876500 | chr16:82401522-82401523 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs544179331 | chr16:82401525-82401526 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs138778407 | chr16:82401536-82401537 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs149385072 | chr16:82401569-82401570 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs552605000 | chr16:82401593-82401594 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs566259668 | chr16:82401602-82401603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs144670254 | chr16:82401608-82401609 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs576953271 | chr16:82401651-82401652 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs12934031 | chr16:82401677-82401678 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs376355036 | chr16:82401678-82401679 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs528684410 | chr16:82401682-82401683 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs372354548 | chr16:82401683-82401684 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs546656207 | chr16:82401684-82401685 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 18632612 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16702952 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Prostate cancer | 19242612 | CNVD |
Cancer | 22429812 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Melanoma | 18172304 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 17001317 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17603634 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 17245344 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21806811 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Lung cancer | 18438408 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 21364760 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Autism | 21865298 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Cancer | 20164920 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16461572 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Ovarian cancer | 21781307 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:82393200-82401800 | Weak transcription | Gastric | stomach |
2 | chr16:82401000-82401200 | Bivalent Enhancer | H1 Derived Mesenchymal Stem Cells | ES cell derived |
3 | chr16:82401000-82402800 | Weak transcription | Aorta | Aorta |
4 | chr16:82401800-82402000 | Enhancers | Gastric | stomach |
5 | chr16:82401800-82402200 | Enhancers | Primary T cells fromperipheralblood | blood |
6 | chr16:82401800-82402400 | Enhancers | Brain Hippocampus Middle | brain |
7 | chr16:82401800-82402400 | Enhancers | Fetal Muscle Trunk | muscle |
8 | chr16:82401800-82402400 | Enhancers | Fetal Stomach | stomach |
9 | chr16:82402000-82402400 | Enhancers | Brain Cingulate Gyrus | brain |
10 | chr16:82402000-82402600 | Weak transcription | Gastric | stomach |
11 | chr16:82402400-82402800 | Weak transcription | Fetal Stomach | stomach |